Updated:
Columbus Venture Capital
Columbus Venture Capital invests in high-growth technology and life science companies from offices in Denmark, the UK, Spain, and multiple US cities.
Columbus Venture Capital
Columbus Venture Capital invests in high-growth technology and life science companies from offices in Denmark, the UK, Spain, and multiple US cities. It targets deep tech, life sciences, and enterprise software across venture capital stages. Portfolio holdings include Nuevolution and a US-based drug developer, per public records from 2020. Team size and assets under management are not publicly disclosed. The firm raises funds from institutional investors, and its governance and succession structure remain opaque due to limited public disclosures.
General information
Firm type
Venture Capital
Location
Region
Europe
Country
Denmark
City
Valencia
Corporate office
Copenhagen, Denmark
Additional offices
London, United Kingdom · Pasadena, United States · Lincoln, United States · Alexandria, United States · Boston, United States · Donostia-San Sebastian, Spain
Sector focus
Frequently asked questions
Who runs investment decisions at Columbus Venture Capital?
The firm's investment leadership is not publicly disclosed. Public records do not name specific managing partners or CIOs for Columbus Venture Capital as of 2026.
How does Columbus Venture Capital source proprietary deal flow?
The firm's multi-continent office network — covering Denmark, the UK, Spain, and several US cities — suggests it sources deals through local relationships in each region. No specific sourcing methodology is publicly detailed.
Is Columbus Venture Capital structured as a single family office or does it operate more like a venture firm?
Available public information characterizes Columbus Venture Capital as a venture capital firm, not a family office. It raises and deploys institutional capital into early-stage companies.
What investment stages does Columbus Venture Capital typically target?
The firm's focus on deep tech and life sciences, along with its multi-office geography, suggests an early-stage venture capital strategy. Exact stage preferences (seed, Series A, etc.) are not publicly specified.
Which sectors does Columbus Venture Capital explicitly avoid?
No public information identifies sectors the firm explicitly avoids. Based on its disclosed focus on deep tech and life sciences, it likely avoids consumer-facing or late-stage private equity.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on venture capital firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: